{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:00:30Z","timestamp":1790208030387,"version":"4.1.0"},"reference-count":101,"publisher":"Georg Thieme Verlag KG","issue":"10","funder":[{"name":"Ministry of Health, Labor and Welfare of Japan","award":["21FC1008"],"award-info":[{"award-number":["21FC1008"]}],"id":[{"id":"https:\/\/ror.org\/03mwa7s65","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Thromb Haemost"],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:p>Thrombin burst is an important mechanism for hemostasis, which is enhancement and amplification of the coagulation cycle, especially activation of coagulation factors XI, VIII, and V by thrombin on the activated platelets. Thrombin burst monitoring has been performed using hemostatic molecular markers, thrombin generation test (TGT), thromboelastography (TEG), and clot waveform analysis (CWA). In particular, CWA is a routine laboratory test that is neither time consuming nor expensive. Arterial thromboses, such as acute myocardial thrombosis and acute cerebral thrombosis, are associated with excessive condition of thrombin burst, and clotting time using a small amount of thrombin in CWA can detect activated or procoagulant platelets. Thrombin burst deficiency is caused by abnormalities of platelets such as thrombocytopenia or clotting factors such as hemophilia and acquired clotting factor deficiency, showing different CWA patterns. Patients with clotting factor VIII inhibitors are treated with bypass therapy, such as recombinant activated clotting factor VII and activated prothrombin complex concentrate, which can be monitored by CWA, TEG, or TGT.<\/jats:p>","DOI":"10.1055\/a-2703-4175","type":"journal-article","created":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T23:41:07Z","timestamp":1758238867000},"page":"0983-0990","source":"Crossref","is-referenced-by-count":4,"title":["Evaluation of Deficiency and Excessive Condition of Thrombin Burst Using Laboratory Tests"],"prefix":"10.1055","volume":"126","author":[{"given":"Hideo","family":"Wada","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Mie Prefectural General Medical Center, Yokkaichi, Mie, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuya","family":"Shiraki","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Mie Prefectural General Medical Center, Yokkaichi, Mie, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideto","family":"Shimpo","sequence":"additional","affiliation":[{"name":"Mie Prefectural General Medical Center, Yokkaichi, Mie, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiyuki","family":"Miyata","sequence":"additional","affiliation":[{"name":"Department of Cerebrovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan"},{"name":"Department of Biomedical Engineering, Osaka Institute of Technology, Asahiku, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2025,10,1]]},"reference":[{"issue":"10","key":"ref1","doi-asserted-by":"crossref","first-page":"797","DOI":"10.2174\/0929867033457728","article-title":"New insights into the coagulation system and implications for new therapeutic options with recombinant factor VIIa","volume":"10","author":"A Veldman","year":"2003","journal-title":"Curr Med Chem"},{"issue":"12","key":"ref2","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1021\/bi00683a012","article-title":"The control of prothrombin conversion. Kinetic control by mechanisms inherent in two activation pathways","volume":"14","author":"S A Silverberg","year":"1975","journal-title":"Biochemistry"},{"issue":"04","key":"ref3","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1046\/j.1365-2516.1998.440331.x","article-title":"Newer concepts of blood coagulation","volume":"4","author":"H R Roberts","year":"1998","journal-title":"Haemophilia"},{"issue":"02","key":"ref4","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0308-2261(21)00478-1","article-title":"Formation of the fibrin clot: the balance of procoagulant and inhibitory factors","volume":"14","author":"B L\u00e4mmle","year":"1985","journal-title":"Clin Haematol"},{"issue":"08","key":"ref5","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1111\/jth.14487","article-title":"Blood coagulation factor Va's key interactive residues and regions for prothrombinase assembly and prothrombin binding","volume":"17","author":"M Schreuder","year":"2019","journal-title":"J Thromb Haemost"},{"issue":"S 01","key":"ref6","doi-asserted-by":"crossref","first-page":"S107","DOI":"10.1097\/00001721-200004001-00020","article-title":"NovoSeven as a universal haemostatic agent","volume":"11","author":"U Hedner","year":"2000","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"06","key":"ref7","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1097\/00043426-200306000-00015","article-title":"Novel applications of recombinant factor VIIa for the management of pediatric coagulopathic diseases","volume":"25","author":"P Mathew","year":"2003","journal-title":"J Pediatr Hematol Oncol"},{"issue":"02","key":"ref8","first-page":"112","article-title":"Potential role of recombinant factor VIIa as a hemostatic agent","volume":"1","author":"U Hedner","year":"2003","journal-title":"Clin Adv Hematol Oncol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1076029620912027","DOI":"10.1177\/1076029620912027","article-title":"Update on the clot waveform analysis","volume":"26","author":"H Wada","year":"2020","journal-title":"Clin Appl Thromb Hemost"},{"issue":"01","key":"ref10","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.thromres.2004.02.009","article-title":"The inhibitory effect of melagatran, the active form of the oral direct thrombin inhibitor ximelagatran, compared with enoxaparin and r-hirudin on ex vivo thrombin generation in human plasma","volume":"113","author":"S L Bostr\u00f6m","year":"2004","journal-title":"Thromb Res"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1477-9560-4-5","article-title":"Thrombin generation by activated factor VII on platelet activated by different agonists. Extending the cell-based model of hemostasis","volume":"4","author":"R Altman","year":"2006","journal-title":"Thromb J"},{"issue":"02","key":"ref12","first-page":"142","article-title":"Exchange transfusion activates coagulation and alters the coagulation profile in newborn infants","volume":"96","author":"S L\u00e5ngstr\u00f6m","year":"2006","journal-title":"Thromb Haemost"},{"issue":"05","key":"ref13","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.thromres.2011.01.001","article-title":"Coagulation parameters in patients receiving dabigatran etexilate or rivaroxaban: two observational studies in patients undergoing total hip or total knee replacement","volume":"127","author":"G Freyburger","year":"2011","journal-title":"Thromb Res"},{"issue":"04","key":"ref14","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1097\/TA.0000000000001637","article-title":"Clot dynamics and mortality: the MA-R ratio","volume":"83","author":"S A Savage","year":"2017","journal-title":"J Trauma Acute Care Surg"},{"issue":"01","key":"ref15","first-page":"110","article-title":"Cocaine use is associated with more rapid clot formation and weaker clot strength in acute stroke patients","volume":"2","author":"T S Almaghrabi","year":"2019","journal-title":"Int J Cerebrovasc Dis Stroke"},{"issue":"21","key":"ref16","doi-asserted-by":"crossref","first-page":"4840","DOI":"10.3390\/jcm10214840","article-title":"The reevaluation of thrombin time using a clot waveform analysis","volume":"10","author":"H Wada","year":"2021","journal-title":"J Clin Med"},{"issue":"20","key":"ref17","doi-asserted-by":"crossref","first-page":"6142","DOI":"10.3390\/jcm11206142","article-title":"A clot waveform analysis of thrombin time using a small amount of thrombin is useful for evaluating the clotting activity of plasma independent of the presence of emicizumab","volume":"11","author":"H Wada","year":"2022","journal-title":"J Clin Med"},{"issue":"01","key":"ref18","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1161\/01.ATV.0000193624.28251.83","article-title":"What does it take to make the perfect clot?","volume":"26","author":"D M Monroe","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"01","key":"ref19","doi-asserted-by":"crossref","first-page":"100018","DOI":"10.1016\/j.rpth.2022.100018","article-title":"Thrombin generation and implications for hemophilia therapies: a narrative review","volume":"7","author":"R F Sidonio Jr","year":"2022","journal-title":"Res Pract Thromb Haemost"},{"issue":"09","key":"ref20","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1161\/01.ATV.0000031340.68494.34","article-title":"Platelets and thrombin generation","volume":"22","author":"D M Monroe","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"S 01","key":"ref21","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/jth.12228","article-title":"Encryption and decryption of tissue factor","volume":"11","author":"V M Chen","year":"2013","journal-title":"J Thromb Haemost"},{"issue":"08","key":"ref22","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1111\/j.1538-7836.2004.00828.x","article-title":"Factor VIIa-mediated tenase function on activated platelets under flow","volume":"2","author":"M S Goel","year":"2004","journal-title":"J Thromb Haemost"},{"issue":"01","key":"ref23","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1538-7836.2005.01630.x","article-title":"Thrombin generation in vascular tissue","volume":"4","author":"A Pathak","year":"2006","journal-title":"J Thromb Haemost"},{"issue":"02","key":"ref24","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1161\/01.ATV.14.2.265","article-title":"Fluorogenic assay of activated factor VII. Plasma factor VIIa levels in relation to arterial cardiovascular diseases in Japanese","volume":"14","author":"K Kario","year":"1994","journal-title":"Arterioscler Thromb"},{"issue":"52","key":"ref25","doi-asserted-by":"crossref","first-page":"42887","DOI":"10.1074\/jbc.M505506200","article-title":"The tissue factor requirement in blood coagulation","volume":"280","author":"T Orfeo","year":"2005","journal-title":"J Biol Chem"},{"issue":"03","key":"ref26","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1055\/s-0037-1614486","article-title":"Contribution of erythrocytes to thrombin generation in whole blood","volume":"81","author":"V Peyrou","year":"1999","journal-title":"Thromb Haemost"},{"issue":"02","key":"ref27","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.bcmd.2005.12.016","article-title":"Collagen-induced platelet activation","volume":"36","author":"R W Farndale","year":"2006","journal-title":"Blood Cells Mol Dis"},{"issue":"11","key":"ref28","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/j.jacc.2010.11.024","article-title":"Clopidogrel-drug interactions","volume":"57","author":"E R Bates","year":"2011","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"ref29","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1160\/TH17-03-0219","article-title":"Protease-activated receptor PAR-4: an inducible switch between thrombosis and vascular inflammation?","volume":"117","author":"A C Fender","year":"2017","journal-title":"Thromb Haemost"},{"issue":"20","key":"ref30","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1182\/blood-2017-05-787259","article-title":"Procoagulant platelets: generation, function, and therapeutic targeting in thrombosis","volume":"130","author":"E O Agbani","year":"2017","journal-title":"Blood"},{"issue":"24","key":"ref31","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1182\/blood.2024025476","article-title":"Procoagulant platelet activation promotes venous thrombosis","volume":"144","author":"R Kaiser","year":"2024","journal-title":"Blood"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.actbio.2016.06.002","article-title":"Degradation and hemostatic properties of polyphosphate coacervates","volume":"41","author":"A Momeni","year":"2016","journal-title":"Acta Biomater"},{"issue":"11","key":"ref33","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1111\/jth.15066","article-title":"Platelet polyphosphate induces fibroblast chemotaxis and myofibroblast differentiation","volume":"18","author":"P M Suess","year":"2020","journal-title":"J Thromb Haemost"},{"issue":"07","key":"ref34","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1111\/trf.13623","article-title":"Transfusion management of factor V deficiency: three case reports and review of the literature","volume":"56","author":"C Gavva","year":"2016","journal-title":"Transfusion"},{"issue":"04","key":"ref35","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1055\/s-0034-1544002","article-title":"Procoagulant platelets and the pathways leading to cell death","volume":"41","author":"V M Hua","year":"2015","journal-title":"Semin Thromb Hemost"},{"issue":"09","key":"ref36","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1007\/s00108-010-2595-4","article-title":"[Pathophysiology and biochemistry of platelets]","volume":"51","author":"K Jurk","year":"2010","journal-title":"Internist (Berl)"},{"issue":"07","key":"ref37","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1080\/09537104.2021.1904133","article-title":"Aquaporins in platelet function","volume":"32","author":"E O Agbani","year":"2021","journal-title":"Platelets"},{"issue":"S 02","key":"ref38","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1016\/S0049-3848(16)30355-3","article-title":"Platelets and coagulation in thrombus formation: aberrations in the Scott syndrome","volume":"141","author":"J P van Geffen","year":"2016","journal-title":"Thromb Res"},{"issue":"01","key":"ref39","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.cell.2012.07.036","article-title":"TMEM16F forms a Ca2+-activated cation channel required for lipid scrambling in platelets during blood coagulation","volume":"151","author":"H Yang","year":"2012","journal-title":"Cell"},{"issue":"11","key":"ref40","doi-asserted-by":"crossref","first-page":"e163808","DOI":"10.1172\/JCI163808","article-title":"TMEM16E regulates endothelial cell procoagulant activity and thrombosis","volume":"133","author":"A A Schmaier","year":"2023","journal-title":"J Clin Invest"},{"issue":"S 01","key":"ref41","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/ijlh.13197","article-title":"Procoagulant platelets: laboratory detection and clinical significance","volume":"42","author":"I Tohidi-Esfahani","year":"2020","journal-title":"Int J Lab Hematol"},{"issue":"01","key":"ref42","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s13054-021-03524-6","article-title":"Endotheliopathy in septic conditions: mechanistic insight into intravascular coagulation","volume":"25","author":"T Ito","year":"2021","journal-title":"Crit Care"},{"issue":"01","key":"ref43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/blood.V76.1.1.1","article-title":"Surface-dependent reactions of the vitamin K-dependent enzyme complexes","volume":"76","author":"K G Mann","year":"1990","journal-title":"Blood"},{"issue":"12","key":"ref44","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1161\/01.CIR.93.12.2121","article-title":"Temporal relation between ischemic episodes and activation of the coagulation system in unstable angina","volume":"93","author":"L M Biasucci","year":"1996","journal-title":"Circulation"},{"issue":"11","key":"ref45","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1161\/01.ATV.16.11.1327","article-title":"Postprandial elevation of activated factor VII in young adults","volume":"16","author":"R Kapur","year":"1996","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"07","key":"ref46","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1111\/j.1538-7836.2006.02028.x","article-title":"Thrombin generation during reperfusion after coronary artery bypass surgery associates with postoperative myocardial damage","volume":"4","author":"P Raivio","year":"2006","journal-title":"J Thromb Haemost"},{"issue":"18","key":"ref47","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1016\/j.jacc.2007.11.083","article-title":"Acute onset human atrial fibrillation is associated with local cardiac platelet activation and endothelial dysfunction","volume":"51","author":"J G Akar","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.colsurfb.2018.11.066","article-title":"Synthetic anionic surfaces can replace microparticles in stimulating burst coagulation of blood plasma","volume":"175","author":"A Contreras-Garc\u00eda","year":"2019","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"11","key":"ref49","doi-asserted-by":"crossref","first-page":"4355","DOI":"10.1182\/blood-2002-08-2400","article-title":"Estimating the rate of thrombin and fibrin generation in vivo during cardiopulmonary bypass","volume":"101","author":"W L Chandler","year":"2003","journal-title":"Blood"},{"issue":"06","key":"ref50","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1111\/j.1538-7836.2006.01942.x","article-title":"Elevated levels of soluble fibrin or D-dimer indicate high risk of thrombosis","volume":"4","author":"H Wada","year":"2006","journal-title":"J Thromb Haemost"},{"issue":"03","key":"ref51","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1177\/1076029607309176","article-title":"Elevated levels of prothrombin fragment 1 + 2 indicate high risk of thrombosis","volume":"14","author":"S Ota","year":"2008","journal-title":"Clin Appl Thromb Hemost"},{"issue":"07","key":"ref52","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.3390\/jcm12072597","article-title":"Plasma soluble fibrin is useful for the diagnosis of thrombotic diseases","volume":"12","author":"M Ezaki","year":"2023","journal-title":"J Clin Med"},{"issue":"15","key":"ref53","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.3390\/jcm10153408","article-title":"Soluble C-type lectin-like receptor 2 elevation in patients with acute cerebral infarction","volume":"10","author":"A Nishigaki","year":"2021","journal-title":"J Clin Med"},{"issue":"05","key":"ref55","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1373\/clinchem.2015.248625","article-title":"Thrombin generation assay and its application in the clinical laboratory","volume":"62","author":"A Tripodi","year":"2016","journal-title":"Clin Chem"},{"issue":"01","key":"ref56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MBC.0000000000001170","article-title":"Thrombin generation assay: the present and the future","volume":"34","author":"Y Wu","year":"2023","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"03","key":"ref57","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/SHK.0000000000000281","article-title":"Noble-Collip drum trauma induces disseminated intravascular coagulation but not acute coagulopathy of trauma-shock","volume":"43","author":"M Hayakawa","year":"2015","journal-title":"Shock"},{"issue":"07","key":"ref58","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1055\/s-0030-1265295","article-title":"Thrombin generation testing for monitoring hemophilia treatment: a clinical perspective","volume":"36","author":"G L Salvagno","year":"2010","journal-title":"Semin Thromb Hemost"},{"issue":"02","key":"ref59","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1080\/00365513.2016.1271906","article-title":"Effects of hemolysis and lipemia interference on kaolin-activated thromboelastography, and comparison with conventional coagulation tests","volume":"77","author":"N Tang","year":"2017","journal-title":"Scand J Clin Lab Invest"},{"issue":"02","key":"ref60","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1939-165X.2010.00224.x","article-title":"Effect of hemolysis on canine kaolin-activated thromboelastography values and ADVIA 2120 platelet activation indices","volume":"39","author":"N B Bauer","year":"2010","journal-title":"Vet Clin Pathol"},{"issue":"06","key":"ref61","doi-asserted-by":"crossref","first-page":"531","DOI":"10.3343\/alm.2023.43.6.531","article-title":"Clot waveform analysis for hemostatic abnormalities","volume":"43","author":"H Wada","year":"2023","journal-title":"Ann Lab Med"},{"issue":"03","key":"ref62","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1097\/TA.0000000000003442","article-title":"Variations in clot phenotype following injury: the MA-R ratio and fragile clots","volume":"92","author":"J Harrington","year":"2022","journal-title":"J Trauma Acute Care Surg"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1177\/10760296251331606","article-title":"Clinical application of clot waveform analysis","volume":"31","author":"H Wada","year":"2025","journal-title":"Clin Appl Thromb Hemost"},{"issue":"23","key":"ref64","doi-asserted-by":"crossref","first-page":"7181","DOI":"10.3390\/jcm13237181","article-title":"Enhanced hypercoagulability using clot waveform analysis in patients with acute myocardial infarction and acute cerebral infarction","volume":"13","author":"J Masuda","year":"2024","journal-title":"J Clin Med"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.thromres.2020.06.018","article-title":"Effects of platelet and phospholipids on clot formation activated by a small amount of tissue factor","volume":"193","author":"H Wada","year":"2020","journal-title":"Thromb Res"},{"issue":"13","key":"ref66","doi-asserted-by":"crossref","first-page":"3857","DOI":"10.3390\/jcm13133857","article-title":"Evaluating factor VIII concentrates using clot waveform analysis","volume":"13","author":"H Wada","year":"2024","journal-title":"J Clin Med"},{"issue":"24","key":"ref67","doi-asserted-by":"crossref","first-page":"5987","DOI":"10.3390\/jcm10245987","article-title":"Clot waveform analysis demonstrates low blood coagulation ability in patients with idiopathic thrombocytopenic purpura","volume":"10","author":"H Wada","year":"2021","journal-title":"J Clin Med"},{"issue":"05","key":"ref68","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/j.jtha.2024.01.021","article-title":"High factor VIII concentrations interfere with glycoprotein VI-mediated platelet activation in vitro","volume":"22","author":"R Sekar","year":"2024","journal-title":"J Thromb Haemost"},{"issue":"01","key":"ref69","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/hae.15147","article-title":"Modulation of haemostatic balance in combined von Willebrand disease and antithrombin deficiency: a comprehensive family study","volume":"31","author":"B Pezeshkpoor","year":"2025","journal-title":"Haemophilia"},{"issue":"19","key":"ref70","doi-asserted-by":"crossref","first-page":"6320","DOI":"10.3390\/jcm12196320","article-title":"The evaluation of clot waveform analyses for assessing hypercoagulability in patients treated with factor VIII concentrate","volume":"12","author":"T Matsumoto","year":"2023","journal-title":"J Clin Med"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1053\/j.seminhematol.2003.11.002","article-title":"Dose optimization of recombinant factor VIIa for control of mild to moderate bleeds in inhibitor patients: improved efficacy with higher dosing","volume":"41","author":"T C Abshire","year":"2004","journal-title":"Semin Hematol"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12959-019-0201-0","article-title":"Usefulness of the APTT waveform for the diagnosis of DIC and prediction of the outcome or bleeding risk","volume":"17","author":"K Suzuki","year":"2019","journal-title":"Thromb J"},{"issue":"02","key":"ref73","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.tmrv.2016.01.001","article-title":"New insights into the treatment of Glanzmann thrombasthenia","volume":"30","author":"M C Poon","year":"2016","journal-title":"Transfus Med Rev"},{"issue":"04","key":"ref74","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1055\/s-2000-8455","article-title":"The factor VII-platelet interplay: effectiveness of recombinant factor VIIa in the treatment of bleeding in severe thrombocytopathia","volume":"26","author":"D M Monroe","year":"2000","journal-title":"Semin Thromb Hemost"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1177\/10760296231161591","article-title":"The detection of hypercoagulability in patients with acute cerebral infarction using a clot waveform analysis","volume":"29","author":"T Kamon","year":"2023","journal-title":"Clin Appl Thromb Hemost"},{"issue":"22","key":"ref76","doi-asserted-by":"crossref","first-page":"5352","DOI":"10.3390\/jcm10225352","article-title":"A clot waveform analysis showing a hypercoagulable state in patients with malignant neoplasms","volume":"10","author":"M Kobayashi","year":"2021","journal-title":"J Clin Med"},{"issue":"09","key":"ref77","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1345\/aph.1P785","article-title":"Bivalirudin for anticoagulation during hypothermic cardiopulmonary bypass and recombinant factor VIIa for iatrogenic coagulopathy","volume":"45","author":"E L Nagle","year":"2011","journal-title":"Ann Pharmacother"},{"issue":"01","key":"ref78","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1051\/ject\/201143019","article-title":"Thrombography reveals thrombin generation potential continues to deteriorate following cardiopulmonary bypass surgery despite adequate hemostasis","volume":"43","author":"R K Wong","year":"2011","journal-title":"J Extra Corpor Technol"},{"key":"ref79","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.thromres.2021.03.030","article-title":"Evaluation of hemostatic abnormalities in patients who underwent major hepatobiliary pancreatic surgery using activated partial thromboplastin time-clot waveform analysis","volume":"201","author":"K Maeda","year":"2021","journal-title":"Thromb Res"},{"issue":"11","key":"ref80","doi-asserted-by":"crossref","first-page":"3487","DOI":"10.3390\/jcm9113487","article-title":"Covid-19-associated coagulopathy: biomarkers of thrombin generation and fibrinolysis leading the outcome","volume":"9","author":"M Ranucci","year":"2020","journal-title":"J Clin Med"},{"issue":"01","key":"ref81","doi-asserted-by":"crossref","first-page":"e000703","DOI":"10.1136\/tsaco-2021-000703","article-title":"Quantification of von Willebrand factor and ADAMTS-13 after traumatic injury: a pilot study","volume":"6","author":"T A MacArthur","year":"2021","journal-title":"Trauma Surg Acute Care Open"},{"issue":"12","key":"ref82","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1016\/j.bpj.2016.10.030","article-title":"A mathematical model of venous thrombosis initiation","volume":"111","author":"P Elizondo","year":"2016","journal-title":"Biophys J"},{"issue":"01","key":"ref83","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s11102-013-0467-3","article-title":"Thrombin generation in Cushing's syndrome: do the conventional clotting indices tell the whole truth?","volume":"17","author":"S Koutroumpi","year":"2014","journal-title":"Pituitary"},{"issue":"02","key":"ref84","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.atherosclerosis.2010.06.028","article-title":"Haemostatic alterations in overweight children: associations between metabolic syndrome, thrombin generation, and fibrinogen levels","volume":"212","author":"P Fritsch","year":"2010","journal-title":"Atherosclerosis"},{"issue":"01","key":"ref85","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.atherosclerosis.2011.01.042","article-title":"Normalization of haemostatic alterations in overweight children with weight loss due to lifestyle intervention","volume":"216","author":"P Fritsch","year":"2011","journal-title":"Atherosclerosis"},{"key":"ref86","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1053\/j.seminhematol.2003.11.008","article-title":"Dosing with recombinant factor viia based on current evidence","volume":"41","author":"U Hedner","year":"2004","journal-title":"Semin Hematol"},{"issue":"02","key":"ref87","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2165\/00063030-200822020-00005","article-title":"Recombinant factor VIIa (eptacog alfa): a review of its use in congenital hemophilia with inhibitors, acquired hemophilia, and other congenital bleeding disorders","volume":"22","author":"K F Croom","year":"2008","journal-title":"BioDrugs"},{"issue":"02","key":"ref88","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/j.1365-2516.2005.01075.x","article-title":"Dose effect and efficacy of rFVIIa in the treatment of haemophilia patients with inhibitors: analysis from the Hemophilia and Thrombosis Research Society Registry","volume":"11","author":"R Parameswaran","year":"2005","journal-title":"Haemophilia"},{"issue":"04","key":"ref89","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/hae.12873","article-title":"Pro- and anticoagulant factors facilitate thrombin generation and balance the haemostatic response to FEIBA(\u00ae) in prophylactic therapy","volume":"22","author":"K Varadi","year":"2016","journal-title":"Haemophilia"},{"issue":"03","key":"ref90","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1177\/1076029607302567","article-title":"Administration of recombinant activated factor VII (NovoSeven) in three cases of uncontrolled bleeding caused by disseminated intravascular coagulopathy","volume":"13","author":"S Schmid","year":"2007","journal-title":"Clin Appl Thromb Hemost"},{"issue":"12","key":"ref91","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/sj.bmt.1703731","article-title":"Treatment of diffuse alveolar hemorrhage after allogeneic bone marrow transplant with recombinant factor VIIa","volume":"30","author":"K Hicks","year":"2002","journal-title":"Bone Marrow Transplant"},{"issue":"03","key":"ref92","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1517\/14740338.4.3.557","article-title":"The safety and efficacy of the administration of recombinant activated factor VII in major surgery and trauma patients","volume":"4","author":"S J Wilson","year":"2005","journal-title":"Expert Opin Drug Saf"},{"issue":"09","key":"ref93","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1056\/NEJMoa1703068","article-title":"Emicizumab prophylaxis in hemophilia A with inhibitors","volume":"377","author":"J Oldenburg","year":"2017","journal-title":"N Engl J Med"},{"issue":"09","key":"ref94","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1056\/NEJMoa1803550","article-title":"Emicizumab prophylaxis in patients who have hemophilia A without inhibitors","volume":"379","author":"J Mahlangu","year":"2018","journal-title":"N Engl J Med"},{"issue":"05","key":"ref95","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1097\/TA.0000000000001402","article-title":"1: 1 Transfusion strategies are right for the wrong reasons","volume":"82","author":"S A Savage","year":"2017","journal-title":"J Trauma Acute Care Surg"},{"issue":"05","key":"ref96","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.jacbts.2016.05.002","article-title":"Direct thrombin inhibitors prevent left atrial remodeling associated with heart failure in rats","volume":"1","author":"C Jumeau","year":"2016","journal-title":"JACC Basic Transl Sci"},{"issue":"03","key":"ref97","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1161\/ATVBAHA.110.202978","article-title":"Rivaroxaban: a new oral factor Xa inhibitor","volume":"30","author":"E Perzborn","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"05","key":"ref98","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1055\/s-0038-1648946","article-title":"The effect of subcutaneous injection of unfractionated and low molecular weight heparin on thrombin generation in platelet rich plasma\u2014a study in human volunteers","volume":"72","author":"A V Bendetowicz","year":"1994","journal-title":"Thromb Haemost"},{"issue":"02","key":"ref99","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2174\/157016107780368325","article-title":"Antagonists of activated factor X and thrombin: innovative antithrombotic agents","volume":"5","author":"M Franchini","year":"2007","journal-title":"Curr Vasc Pharmacol"},{"key":"ref100","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/978-1-0716-3175-1_22","article-title":"An overview of heparin monitoring with the anti-Xa assay","volume":"2663","author":"C L Dean","year":"2023","journal-title":"Methods Mol Biol"},{"key":"ref101","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/978-1-62703-339-8_12","article-title":"Activated clotting time (ACT)","volume":"992","author":"S Horton","year":"2013","journal-title":"Methods Mol Biol"},{"issue":"06","key":"ref102","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1055\/s-0037-1614606","article-title":"Effect of clopidogrel on thrombin generation in platelet-rich plasma in the rat","volume":"81","author":"J P H\u00e9rault","year":"1999","journal-title":"Thromb Haemost"}],"container-title":["Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2703-4175.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T23:12:00Z","timestamp":1790205120000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2703-4175"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,18]]},"references-count":101,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,9,23]]},"published-print":{"date-parts":[[2026,10]]}},"URL":"https:\/\/doi.org\/10.1055\/a-2703-4175","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0340-6245","2567-689X"],"issn-type":[{"value":"0340-6245","type":"print"},{"value":"2567-689X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,9,18]]},"published":{"date-parts":[[2025,9,18]]}}}